We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Getting back to the world of clinical research with Industry Voice! In today's episode, we sit down with Kyla Xue, a managing partner at LSV Capital – a multi-stage investment company from China. Kyla unveils her perspectives on the criteria for selecting portfolio companies, the importance of innovation in biotech and medtechs, and shares insights on how to finance areas like immunology, neuroscience, and synthetic biology.
If you're intrigued by how global life science investments shape our future, this is a must-watch!
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
